Contact the Host for event and ticket information.

Looks like this event has already ended.

Explore the events happening around you, or organize your very own event.

Find events near you Create an event

Xconomy Forum: Boston's War on Cancer

Wednesday, October 20, 2010 from 2:30 PM to 6:00 PM (ET)

Cambridge, United States

Xconomy Forum: Boston's War on Cancer

Ticket Information

Ticket Type Sales End Price Fee Quantity
Saver Rate Ended $295.00 $0.00
Regular Registration Ended $350.00 $0.00
Student Registration   more info Ended $95.00 $0.00
Walk-in Registration Ended $450.00 $0.00
SHARE THIS EVENT

Event Details

Xconomy Forum: Boston's War on Cancer

Cancer might be the mother of all pharmaceutical opportunities for the 21st century. Advances in biology over the past 40 years have ushered in a wave of targeted therapies that have proven in some cases to be more effective and more lucrative than traditional chemotherapy and radiation treatments. Drugmakers are now testing some 860 cancer drugs in clinical trials and pursuing a global cancer market worth an estimated $84 billion by 2012.

Enormous challenges remain in a field where only one out of every 10 drug candidates navigates the required clinical trials, and successful drugs often only help one-fourth of patients. Yet many of the most creative advances in the field are coming from New England. We will convene some of the leaders who are crafting these new strategies for fighting this complex and deadly disease.

Keynote speakers:
Deborah Dunsire, CEO, Millennium: The Takeda Oncology Company
Tyler Jacks, Director, David H. Koch Institute for Integrative Cancer Research

Confirmed speakers include:
Alexis Borisy, CEO, Foundation Medicine, Entrepreneur-in-Residence, Third Rock Ventures
Doug Fambrough, CEO, Dicerna Therapeutics
Mark Goldsmith, CEO, Constellation Pharmaceuticals
Tuan Ha-Ngoc, CEO, Aveo Pharmaceuticals
Mike Huckman, SVP, Director of Media Strategy, MS&L
Dave Okrongly, CEO, Quanterix
Adelene Perkins, CEO, Infinity Pharmaceuticals
Nancy Simonian, Chief Medical Officer, Millennium: The Takeda Oncology Company
Sylvia Pagán Westphal, Columnist, Xconomy

Full Agenda here.

Schedule:
Registration: 1:45 – 2:30 pm
Program:
2:30 – 6:00 pm
Networking reception: 6:00 – 7:00 pm

Registration information:
Tickets are transferable but not refundable.
To inquire about press registration, e-mail events@xconomy.com.


EVENT HOST

       Millennium: The Takeda Oncology Company

EVENT SPONSORS

Aderly OnlyLyon               BNY Mellon

Guard Dog Brand Development                   Halloran Consulting

Mintz Levin                 Ropes & Gray

DESIGN SPONSOR

Upstatement

EVENT PARTNER

MassBio

UNDERWRITERS
Aderly/OnlyLyon • Alexandria Real Estate Equities • AMRI • Biogen Idec
BNY Mellon Wealth Management • Cubist Pharmaceuticals • Halloran Consulting Group
Invest Northern Ireland • J. Robert Scott Executive Search • Kauffman Foundation
Science and Technology Directorate, U.S. Department of Homeland Security
UK Trade & Investment • WilmerHale

VENTURE CAPITAL MEMBERS
Advanced Technology Ventures • ARCH Venture Partners
Atlas Venture • Boston Millennia Partners • Excel Venture Management
Flagship Ventures • Flybridge Capital Partners
North Bridge Venture Partners • Polaris Venture Partners

When & Where


35 Landsdowne St.
Cambridge, 02139

Wednesday, October 20, 2010 from 2:30 PM to 6:00 PM (ET)


  Add to my calendar